findmyKOL
Clinical trialNCT05087849CompletedPhase 1/PHASE2Interventional

Intralesional HPV Vaccine for Condylomata

SponsorUniversity of California, San FranciscoEnrollment2CondylomaCondylomata AcuminataHuman Papilloma VirusWartsWarts, Genital
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

This study will investigate whether injecting genital warts with small quantities of the Gardasil 9 vaccine has an effect on the warts.
clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Zuckerberg San Francisco General Hospital

    San Francisco, California, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Nonavalent human papillomavirus vaccine
Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
15 Apr 2022
Primary completion
1 Jul 2024
Completion
1 Jul 2024
Last update posted
2 Oct 2025
Registered enrollment
2
Registry id
NCT05087849
clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.